Oxidative stress and the hypoxic microenvironment play a key role in the progression of human melanoma, one of the most aggressive skin cancers. The aim of our study was to evaluate the effect of Hypericum perforatum extracts of different origins (both commercially available (HpEx2) and laboratory-prepared from wild grown (HpEx12) and in vitro cultured (HpEx13) plants) and hyperforin salt on WM115 primary and WM266-4 lymph node metastatic human melanoma cells cultured under normoxic and hypoxic conditions. The polyphenol content, radical scavenging activity, and hyperforin concentration were determined in the extracts, while cell viability, apoptosis, ROS production, and expression of NRF2 and HO-1, important oxidative stress-related factors, were analyzed after 24 h of cell stimulation with HpExs and hyperforin salt. We found that cytotoxic, pro-apoptotic and antioxidant effects depend on the extract composition, the stage of melanoma progression, and the oxygen level. Hyperforin salt showed lower activity than H. perforatum extracts. Our study for the first time showed that the anticancer activity of H. perforatum extracts differs in normoxia and hypoxia. Importantly, the composition of extracts of various origins, including in vitro cultured, resulting in their unique properties, may be important in the selection of plants for therapeutic application.
1 September 2025 in Journal of Inflammation Research
Background: The role of Fas is crucial for preserving immunotolerance. The mechanisms and roles of Fas/FasL signaling in the immune system are well understood, but the knowledge of how this process is regulated remains limited. Fas-mediated apoptosis is a way of thyrocyte elimination and thyroid destruction in Hashimoto’s thyroiditis (HT). Proinflammatory cytokines, produced abundantly by immune cells in the thyroid in HT, stimulate the expression of Fas in thyrocytes, making them susceptible to apoptosis induced by FasL on the immune cell surface. Purpose: The present study aimed to evaluate the impact of changes in Fas N-glycosylation on the death of human follicular thyroid cells of the Nthy-ori 3– 1 line. Methods: To induce thyrocyte apoptosis, an in vitro model was established. Cells were stimulated with IFNγ to express Fas and treated with the N-glycosylation inhibitors, kifunensine and swainsonine. Then apoptosis was induced by human recombinant FasL. MALDI-Tof mass spectrometry monitored kifunensine- and swainsonine-induced changes in N-glycosylation of Nthy-ori 3– 1 thyrocytes, and cell death was analyzed using flow cytometry (annexin V staining, caspase 3/7 activity, TMRE mitochondrial membrane potential assay) and fluorescence microscopy (DAPI staining). Results: We found that swainsonine reduces Nthy-ori 3– 1 cell apoptosis, caspase 3 and 7 activity, and restores mitochondrial potential. DAPI staining showed a decreased rupture and fragmentation of Nthy-ori 3– 1 cell nuclei in the presence of swainsonine. The protective effect of kifunensine was only shown in the TMRE assay and for the late apoptotic cells in annexin V+/PI+ staining. Conclusion: Our study demonstrated for the first time the anti-apoptotic effect of swainsonine on follicular thyroid cell death through the Fas/FasL signaling pathway. This finding may have later applications in controlling Fas/FasL-induced thyrocyte apoptosis and preventing thyroid destruction in HT.
26 May 2026 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Transport of bioactive molecules via extracellular vesicles (EVs) is one of the mechanisms of intercellular communication. EVs regulate a number of physiological processes in recipient cells, but also contribute to development and progression of many diseases, including cancer. Many glycoproteins are incorporated into EVs, but little is known about their biological significance. Glycosylation can affect sorting of protein into EVs and interaction of EVs with the target cell. Therefore, EV glycome is being investigated for possible diagnostic and therapeutic applications. The aim of this study was structural analysis and identification of N-glycans differentiating EVs from urological cancer cell lines (bladder - T24, prostate - PC-3, and renal - Caki-2) and their non-transformed counterparts (HCV-29, HPrEC and HREpC cells, respectively) using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry (MALDI-TOF). EVs derived from all cancerous cell lines showed increased abundance of oligomannose structures compared to EVs from non-transformed cells. Particularly, increased expression of H8N2, H9N2 and H10N2 structures was observed in EVs derived from all 3 cancer cell lines. Also, overall sialylation was decreased in cancer-derived EVs, with lower expression of H5N4E2, H6N5E1L2 and H6N5E2L1 structures. In addition, we identified structures/subgroups of structures that distinguish EVs from each individual urological cancer cell line from EVs from reference non-transformed cells. The results provide preliminary insight into the structural diversity and biological significance of N-glycans present in EVs derived from urological cancer cells. Identifying EV N-glycan enrichment or depletion patterns that are common to, or specific for studied urological cancers may contribute to development of new diagnostic approaches.